Cargando…
Interleukin‐6/STAT3 signaling as a promising target to improve the efficacy of cancer immunotherapy
Overcoming the immunosuppressive state in tumor microenvironments is a critical issue for improving the efficacy of cancer immunotherapy. Interleukin (IL)‐6, a pleiotropic cytokine, is highly produced in the tumor‐bearing host. Previous studies have indicated that IL‐6 suppresses the antigen present...
Autores principales: | Kitamura, Hidemitsu, Ohno, Yosuke, Toyoshima, Yujiro, Ohtake, Junya, Homma, Shigenori, Kawamura, Hideki, Takahashi, Norihiko, Taketomi, Akinobu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5623748/ https://www.ncbi.nlm.nih.gov/pubmed/28749573 http://dx.doi.org/10.1111/cas.13332 |
Ejemplares similares
-
Lack of interleukin‐6 in the tumor microenvironment augments type‐1 immunity and increases the efficacy of cancer immunotherapy
por: Ohno, Yosuke, et al.
Publicado: (2017) -
IL-11 induces differentiation of myeloid-derived suppressor cells through activation of STAT3 signalling pathway
por: Sumida, Kentaro, et al.
Publicado: (2015) -
Arginase-1 inhibition reduces migration ability and metastatic colonization of colon cancer cells
por: Wang, Xiangdong, et al.
Publicado: (2023) -
Solitary left axillary lymph node metastasis after curative resection of carcinoma at the colostomy site: a case report
por: Imaizumi, Ken, et al.
Publicado: (2016) -
Successful treatment of rectovaginal fistula and rectal stenosis due to perianal Crohn’s disease by dual-port laparoscopic abdominoperineal resection: a report of two cases
por: Matsuzawa, Fumihiko, et al.
Publicado: (2016)